Skip to main content

ADVERTISEMENT

Theodore L. Schreiber, MD

06/19/2008
Background Although clinical trial data suggest that the incidence of hemorrhagic and vascular complications associated with invasive coronary procedures is relatively low, contemporary data from ‘real world, non-trial related’data...
Background Although clinical trial data suggest that the incidence of hemorrhagic and vascular complications associated with invasive coronary procedures is relatively low, contemporary data from ‘real world, non-trial related’data...
Background Although clinical...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Background Although clinical trial data suggest that the incidence of hemorrhagic and vascular complications associated with invasive coronary procedures is relatively low, contemporary data from ‘real world, non-trial related’data...
Background Although clinical trial data suggest that the incidence of hemorrhagic and vascular complications associated with invasive coronary procedures is relatively low, contemporary data from ‘real world, non-trial related’data...
Background Although clinical...
06/19/2008
Cath Lab Digest
Case Report
09/15/2008
ABSTRACT: Atherectomy using the FoxHollow device is an exciting treatment as an alternative to lower extremity arterial bypass for treatment of peripheral vascular disease in symptomatic patients with critical limb ischemia and disabling...
ABSTRACT: Atherectomy using the FoxHollow device is an exciting treatment as an alternative to lower extremity arterial bypass for treatment of peripheral vascular disease in symptomatic patients with critical limb ischemia and disabling...
ABSTRACT: Atherectomy using the...
09/15/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Key words: percutaneous coronary intervention, platelet glycoprotein IIb/IIIa inhibitors, pulmonary hemorrhage In 1983, the description of an antibody that blocked the platelet glycoprotein (GP) IIb/IIIa receptor led to the development of a...
Key words: percutaneous coronary intervention, platelet glycoprotein IIb/IIIa inhibitors, pulmonary hemorrhage In 1983, the description of an antibody that blocked the platelet glycoprotein (GP) IIb/IIIa receptor led to the development of a...
Key words: percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
The following special CME section is underwritten through an educational grant from Possis Medical, Inc. Learning objectives. At the conclusion of this activity, the participant should be able to: 1) describe the impact of thrombus on...
The following special CME section is underwritten through an educational grant from Possis Medical, Inc. Learning objectives. At the conclusion of this activity, the participant should be able to: 1) describe the impact of thrombus on...
The following special CME...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
12/27/2017
To evaluate the clinical features and outcomes of patients with anemia undergoing percutaneous peripheral vascular intervention (PVI) in a contemporary registry, we evaluated the differences in the clinical features and outcomes of patients...
To evaluate the clinical features and outcomes of patients with anemia undergoing percutaneous peripheral vascular intervention (PVI) in a contemporary registry, we evaluated the differences in the clinical features and outcomes of patients...
To evaluate the clinical...
12/27/2017
Journal of Invasive Cardiology
Original Contribution
02/15/2016
An investigation on whether the use of hemodynamic support during PCI can mitigate the adverse prognostic importance of surgical ineligibility. 
An investigation on whether the use of hemodynamic support during PCI can mitigate the adverse prognostic importance of surgical ineligibility. 
An investigation on whether the...
02/15/2016
Journal of Invasive Cardiology